Epithelial-Mesenchymal Transition
"Epithelial-Mesenchymal Transition" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Phenotypic changes of EPITHELIAL CELLS to MESENCHYME type, which increase cell mobility critical in many developmental processes such as NEURAL TUBE development. NEOPLASM METASTASIS and DISEASE PROGRESSION may also induce this transition.
| Descriptor ID |
D058750
|
| MeSH Number(s) |
G04.356.500
|
| Concept/Terms |
Epithelial-Mesenchymal Transition- Epithelial-Mesenchymal Transition
- Epithelial Mesenchymal Transition
- Epithelial-Mesenchymal Transitions
- Transition, Epithelial-Mesenchymal
- Transitions, Epithelial-Mesenchymal
- Epithelial-Mesenchymal Transformation
- Epithelial Mesenchymal Transformation
- Epithelial-Mesenchymal Transformations
- Transformation, Epithelial-Mesenchymal
- Transformations, Epithelial-Mesenchymal
|
Below are MeSH descriptors whose meaning is more general than "Epithelial-Mesenchymal Transition".
Below are MeSH descriptors whose meaning is more specific than "Epithelial-Mesenchymal Transition".
This graph shows the total number of publications written about "Epithelial-Mesenchymal Transition" by people in this website by year, and whether "Epithelial-Mesenchymal Transition" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 1 | 2 |
| 2013 | 3 | 1 | 4 |
| 2014 | 3 | 4 | 7 |
| 2015 | 3 | 4 | 7 |
| 2016 | 0 | 7 | 7 |
| 2017 | 1 | 4 | 5 |
| 2018 | 2 | 4 | 6 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 3 | 4 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 2 | 2 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Epithelial-Mesenchymal Transition" by people in Profiles.
-
Deficient RPE mitochondrial energetics leads to subretinal fibrosis in age-related neovascular macular degeneration. Commun Biol. 2024 Sep 02; 7(1):1075.
-
Ecdysoneless Overexpression Drives Mammary Tumorigenesis through Upregulation of C-MYC and Glucose Metabolism. Mol Cancer Res. 2022 09 02; 20(9):1391-1404.
-
EWI2 prevents EGFR from clustering and endocytosis to reduce tumor cell movement and proliferation. Cell Mol Life Sci. 2022 Jun 30; 79(7):389.
-
Resveratrol Contrasts LPA-Induced Ovarian Cancer Cell Migration and Platinum Resistance by Rescuing Hedgehog-Mediated Autophagy. Cells. 2021 11 17; 10(11).
-
Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling. BMC Neurol. 2021 Jun 23; 21(1):231.
-
Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer. Gastroenterology. 2021 04; 160(5):1771-1783.e1.
-
miR614 Expression Enhances Breast Cancer Cell Motility. Int J Mol Sci. 2020 Dec 24; 22(1).
-
VEGF-C mediates tumor growth and metastasis through promoting EMT-epithelial breast cancer cell crosstalk. Oncogene. 2021 02; 40(5):964-979.
-
Emerging therapeutic targets for neuroblastoma. Expert Opin Ther Targets. 2020 09; 24(9):899-914.
-
?Np63-Regulated Epithelial-to-Mesenchymal Transition State Heterogeneity Confers a Leader-Follower Relationship That Drives Collective Invasion. Cancer Res. 2020 09 15; 80(18):3933-3944.